Resources

Full transcript of Dr. William Polonsky's insights on the challenges of getting patients to prioritize their diabetes care and how to help motivate positive behavior changes for self-care.

In this Exclusive Interview, Dr. William Polonsky talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the difficulties in getting patients to prioritize their diabetes care, but what can be done to help motivate them and turn around poor self-care behaviors.

In part 1 of this Exclusive Interview, Dr. William Polonsky talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the mission when working with a patient with diabetes - making an invisible disease visible, thus making it a priority in the patient's life.

In part 2 of this Exclusive Interview, Dr. William Polonsky talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the impact CGM can have on the effort to make diabetes visible by showing the effects of small behaviors on blood glucose.

In part 3 of this Exclusive Interview, Dr. William Polonsky talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the latest studies regarding diabetes depression and what may actually be going on under the surface.

In part 4 of this Exclusive Interview, Dr. William Polonsky talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the primary motivator for many diabetes patients who are typically slow to care for themselves.

In part 5, the conclusion of this Exclusive Interview, Dr. William Polonsky talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the one question a doctor can ask their patient to really make an impact on their engagement with the patient.

In part 4 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the untapped possibilities of Cycloset.

In this week's Homerun Slides, FDA-approved GLP-1s and GLP-1s in development.

Cause of NAFLD: physical inactivity: Although physical training predominantly enhances muscle insulin sensitivity, cross-sectional epidemiologic data and studies on effects of physical training suggest that exercise may decrease liver fat even in the face of unchanged body weight [50]. In a cross-sectional study in 72,359 healthy Korean adults, subjects who were exercising regularly had a 28–53% lower risk of NAFLD across almost all BMI deciles.